Malin Corporation | MLC - Kapitał Akcyjny





Kapitał Akcyjny Zmiana Data
Akebia Therapeutics USD 265.42M 199K 2025-12
Alaunos Therapeutics USD 2.49M 108K 2026-06
ALKERMES USD 168.03M 489K 2026-09
Dianthus Therapeutics USD 54.8M 215.59K 2026-06
Eurofins Scientific SE EUR 172.35M 5.55M 2026-06
Ionis Pharmaceuticals USD 166.41M 773K 2026-09
IQVIA Holdings USD 164.8M 200K 2026-09
Lonza CHF 68.64M 0 2025-12
Malin Corporation EUR 200K 0 2024-12
Moderna USD 391M 2M 2025-09
Organon & Co USD 262.62M 13K 2026-09
Ovoca Bio EUR 29.49M 0 2025-12
Revvity USD 111.59M 43K 2026-09
Tectonic Therapeutic USD 19.24M 404.78K 2026-06
Viatris USD 1.15B 8.79M 2026-09
Xeris Pharmaceuticals USD 173.59M 1.03M 2026-06